Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer’s disease
Abstract
Neuronal death is a pathological hallmark of Alzheimer's disease. We have shown previously that phosphorylated double-stranded RNA-dependent protein kinase is present in degenerating hippocampal neurons and in senile plaques of Alzheimer's disease brains and that genetically down-regulating double-stranded RNA-dependent protein kinase activity protects against in vitro beta-amyloid peptide neurotoxicity. In this report, we showed that two double-stranded RNA-dependent protein kinase blockers attenuate, in human neuroblastoma cells, beta-amyloid peptide toxicity evaluated by caspase 3 assessment. In addition, we have used the newly engineered APP(SL)/presenilin 1 knock-in transgenic mice, which display a severe neuronal loss in hippocampal regions, to analyze the activation of double-stranded RNA-dependent protein kinase. Western blots revealed the increased levels of activated double-stranded RNA-dependent protein kinase and the inhibition of eukaryotic initiation factor 2 alpha activity in the brains of these double transgenic mice. Phosphorylated RNA-dependent protein kinase-like endoplasmic reticulum-resident kinase was also increased in the brains of these mice. The levels of activated double-stranded RNA-dependent protein kinase were also increased in the brains of patients with Alzheimer's disease. At 3, 6 and 12 months, hippocampal neurons display double stranded RNA-dependent protein kinase labelings in both the nucleus and the cytoplasm. Confocal microscopy showed th…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A progressive increase of apoptotic nuclei is observed at 3, 6 and 12 months of age in APPsl/PS1 KI mice and PKR is closely co-localized with DNA strand breaks in apoptotic nuclei of hippocampal neurons.
“A progressive increase of apoptotic nuclei is also observed at 3, 6 and 12 months of age in these mice and PKR is closely co-localized with DNA strand breaks in apoptotic nuclei of hippocampal neurons [97].”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [97]
The up-regulation of PKR in mononuclear cells does not lead to the cell death observed in cellular models exposed to Aβ, in AD transgenic mice and in brains of AD patients.
“Paradoxically, the up-regulation of PKR in mononuclear cells do not lead to the cell death observed in cellular models exposed to Ap, in AD transgenic mice and in brains of AD patients [50, 95, 97].”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [97]
In brains of APPSL/PS1 KI mice, PKR was early up-regulated before the massive neuronal loss.
“In brains of APPSL/PS1 KI mice, PKR was early up-regulated before the massive neuronal loss [97].”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [97]
In brains of APPslPS1 KI mice, levels of phosphorylated PKR were significantly increased as early as 3 months of age, associated with intraneuronal amyloid peptide, before the massive neuronal death observed at 6 months.
“We can remember that the levels of phosphorylated PKR were significantly increased in brains of APPslPS1 KI mice as early as 3 months of age associated with intraneuronal amyloid peptide before the massive neuronal death observed at 6 months [97].”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [97]
In Alzheimer's disease, eIF2a and p53 are targets of PKR.
“In AD, eIF2a and p53 are targets of PKR [28, 30, 97, 102, 129].”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [97]
Cites
Chang, R. C. C., Wong, A. K. Y., Ng, H.-K., & Hugon, J. (2002) · NeuroReport · doi:10.1097/00001756-200212200-00011 · Cited by 289 · see citing works
Self-citationCuddihy, A. R., Hoi-Tao Wong, A., Wai Ning Tam, N., Li, S., & Koromilas, A. E. (1999) · Oncogene · doi:10.1038/sj.onc.1202620 · Cited by 203 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Translational control in synaptic plasticity and cognitive dysfunction
Buffington, S. A., Huang, W., & Costa-Mattioli, M. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014100 · Cited by 348 · see citing works
Translational Control in the Brain in Health and Disease
Sossin, W. S., & Costa-Mattioli, M. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032912 · Cited by 138 · see citing works
Devi, L., Alldred, M. J., Ginsberg, S. D., & Ohno, M. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-34 · Cited by 129 · see citing works
Faure, A., Verret, L., Bozon, B., El Tannir El Tayara, N., Ly, M., Kober, F., Dhenain, M., Rampon, C., & Delatour, B. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.009 · Cited by 112 · see citing works
PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease
Morel, M., Couturier, J., Lafay‐Chebassier, C., Paccalin, M., & Page, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00849.x · Cited by 47 · see citing works
Self-citationInsights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research
Pádua, M. S., Guil-Guerrero, J. L., Prates, J. A. M., & Lopes, P. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052805 · Cited by 46 · see citing works
Damjanac, M., Page, G., Ragot, S., Laborie, G., Gil, R., Hugon, J., & Paccalin, M. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00688.x · Cited by 31 · see citing works
Self-citation
- Authors
- Page, G., Rioux Bilan, A., Ingrand, S., Lafay-Chebassier, C., Pain, S., Perault Pochat, M. C., Bouras, C., Bayer, T., & Hugon, J.
- Affiliations
- Université de Poitiers (FR)
- University of Geneva (CH)
- Saarland University (DE)
- Corresponding author
- Page, G.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2006
- Volume
- 139
- Issue
- 4
- Pages
- 1343-1354
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2024828025
- Cited by
- 116
- References
- 2
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 6 · 2023: 2 · 2022: 4 · 2021: 7 · 2020: 8 · 2019: 4 · 2018: 8 · 2017: 8 · 2016: 4 · 2015: 6 · 2014: 8 · 2013: 5 · 2012: 5
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Chung Hua University
- Université de Poitiers
- Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (EA 3808)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- double-stranded RNA-dependent protein kinase, neuronal cell death, Alzheimer's disease, amyloid-beta toxicity, caspase-3, hippocampal neurons, DNA strand breaks, apoptosis, neuroprotection, amyloid plaques
- MeSH terms
- Alzheimer Disease, Animals, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Interactions, Enzyme Activation, Enzyme Inhibitors, Humans, Immunohistochemistry, Indoles, Membrane Proteins, Mice, Transgenic, Neuroblastoma, Neurons, Peptide Fragments, Endopeptidases, Blotting, Western, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Cell Death, eIF-2 Kinase, Caspases, In Situ Nick-End Labeling, Cell Line, Tumor, Mice, Caspase 3, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review